Keywords: vernalis, shares, up, serono, returns, anti-inflammatory, drugs

Vernalis shares up 10% as Serono returns anti-inflammatory drugs

Article | 27 October 2008

Print This

Shares in Vernalis rose 10% to 2.93 pence after a portfolio of compounds it licensed to Swiss firm Serono reverted to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in